The Plate for Clutch Parts of 507 Type
Â
| Model number | ES-LB002 |
| Material | Steel |
| Color | Golden |
| Compressor Type | 507 |
| Application | Clutch Parts |
Packing: Customized or neutralÂ
Payment: T/T or Western Union
     30% in advance to start production,the balance paid before shipmentÂ
Delivery: 3 or 5 days for sample order
     15 days for the big quantityÂ
Shipping Ways: By express(Fedex,DHL,TNT,EMS) or sea or airÂ
Company InformationÂ
ESIA AIR-CON (CHINA) LIMITED is a professional manufacturer and sales enterprise of auto mobile air conditioning parts.Â
We supply auto air conditioning parts with good quality and competitive price and we can also produce goods as your design.
Moreover we have a kindly cooperation relationship with correlative factories and enterprise abroad and have a various of advanced production technology.Â
If you are interested in our products, please feel free to contact with us at any time.
Ruxolitinib is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.
Ruxolitinib is a Janus kinase inhibitor that is used in the treatment of intermediate or high risk myelofibrosis and resistant forms of polycythemia vera and graft-vs-host disease. Ruxolitinib is associated with transient and usually mild elevations in serum aminotransferase during therapy and to rare instances of self-limited, clinically apparent idiosyncratic acute liver injury and to cases of reactivation of hepatitis B in susceptible individuals.
Ruxolitinib cas 941678-49-5; INCB018424; Ruxolitinib (INCB018424); (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile; INCB-018424; INCB 018424; UNII-82S8X8XX8H;
Ruxolitinib API Cas 941678-49-5,INCB018424 Ruxolitinib Offering,Jakafi Roxolitinib Offering.
Ruxolitinib cas 941678-49-5; INCB018424; Ruxolitinib (INCB018424); (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile; INCB-018424; INCB 018424; UNII-82S8X8XX8H;
 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com